Charmacy Pharmaceutical Co., Ltd. Class H Financial Overview
Charmacy Pharmaceutical Co., Ltd. Class H's market cap is currently HK$554.04M. The company's EPS TTM is HK$0.216; its P/E ratio is 10.63; and it has a dividend yield of 9.53%. Charmacy Pharmaceutical Co., Ltd. Class H is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
